Proactive against reactive treatment for lichen sclerosus
Lichen sclerosus is a long-term skin condition affecting the vulva, which is the skin on the outside of the vagina. It can cause severe itching, soreness, and skin scarring. Doctors routinely prescribe steroid creams to calm these symptoms, but they are not sure whether it is better to keep using the cream regularly or only use it during flare-ups. This UK study, called the PEARLS trial, compares these two common routines over two years. One group applies steroid cream twice a week to stop symptoms returning. The other group uses the cream only when they feel a flare-up starting. Females aged 5 and older whose symptoms are currently calm and under control can take part. The results will help the NHS provide clearer guidance, reduce discomfort, and lower the risk of long-term skin damage for people living with this condition.
At a glance
What is this study about?
Lichen sclerosus is a chronic condition that affects the vulval skin (the area outside the vagina). It can cause intense itching, pain, and discomfort. If it is not managed well, the inflammation can cause the delicate skin to scar, tighten, or shrink over time. While it can affect females of any age, it is most common in young girls before puberty and women who have gone through the menopause.
Steroid creams and ointments are the standard, effective treatment used across the NHS to calm the skin. However, once the condition is controlled, doctors have different views on the best way to prevent future flares. Some recommend applying the cream regularly, such as twice a week, even when the skin feels completely normal. Others advise waiting until symptoms start to flare up before using the cream again.
The PEARLS study is a nationwide NHS research trial designed to resolve this uncertainty. By following participants over two years, researchers want to see which strategy works best to stop flare-ups, prevent skin scarring, and improve day-to-day comfort. The study will also look at which approach provides the best value for NHS resources.
Key takeaways
- The PEARLS study compares using steroid cream twice weekly versus using it only during flare-ups.
- It is open to females aged 5 and over with controlled vulval lichen sclerosus.
- Participants are followed for two years with regular specialist check-ups.
- The study uses standard NHS steroid treatments, not new experimental drugs.
- Optional parts of the study include skin photographs and patient interviews.
Who may be eligible?
This study is open to females aged 5 years and older who have a confirmed diagnosis of vulval lichen sclerosus. To take part, your condition must currently be well-controlled, meaning you are not experiencing active symptoms or a flare-up when you join. Children and teenagers can join with the support and consent of a parent or guardian.
You will not be able to join if you have ever had vulval cancer or precancerous cell changes (known as VIN). The study is also not suitable for anyone who cannot safely use steroid creams, or people currently taking oral immune-suppressing medicines or other medicated vulval creams.
In addition, people who are pregnant, breastfeeding, or who have had gender-affirming surgery involving the vulva are not eligible to take part. If you are unsure whether your current health or treatments affect your eligibility, the study team or your doctor can check this with you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am female and aged 5 years or older.
- I have been diagnosed with vulval lichen sclerosus.
- My symptoms are currently calm and under control.
- I have never had vulval cancer or precancerous vulval changes (VIN).
- I am not currently pregnant or breastfeeding.
- I am not taking oral immune-suppressing tablets.
What does participation involve?
If you decide to join, you will take part for around two years. A computer will randomly assign you to one of two treatment groups. One group will use their prescribed steroid cream twice a week to keep symptoms away. The other group will keep their cream on hand and only apply it when they notice a flare-up starting. Both groups use standard NHS steroid ointments. You will attend regular check-up visits, which the team will aim to schedule alongside your normal clinic appointments. With your permission, close-up photos of the area may be taken at the start to monitor your skin health, and you might be invited to share your thoughts in a short interview. You can also choose whether researchers may check your medical records in the future to monitor your long-term health.
Potential risks and benefits
Locations (22)
- Axess Sexual Health, Royal Liverpool University HospitalCity onlyLiverpool, England
- Liverpool Women's HospitalApproximateLiverpool, England
- Aberdeen Royal InfirmaryApproximateAberdeen, Scotland
- Royal Blackburn HospitalApproximateBlackburn, England
- The James Cook University HospitalApproximateMiddlesbrough, England
- St Mary's HospitalApproximateManchester, England
- Market Street Health Centre, OxleasCity onlyLondon, England
- Whipps Cross University HospitalApproximateLondon, England
- Queen Elizabeth HospitalApproximateGateshead, England
- Florence Nightingale Community HospitalApproximateDerby, England
- Royal Derby HospitalUnverifiedDerby, England
- Churchill HospitalUnverifiedOxford, England
Common questions
Will I be testing a new or experimental drug?
No. The study uses the same standard steroid creams that NHS doctors already prescribe for lichen sclerosus. The trial is only testing how often you should apply it.
Can children join this trial?
Yes. Girls aged 5 and over can take part, provided a parent or guardian gives permission and the child agrees.
Do I have to agree to have photographs taken?
No. Having photographs taken of the vulval skin is completely optional. You can still take part in the main study if you prefer not to have photos taken.
What happens if I get a bad flare-up during the trial?
Your safety and comfort come first. You will be able to treat the flare-up and contact the study team or your doctor for advice and support whenever needed.
Does it cost anything to take part?
No. The trial is funded by the National Institute for Health and Care Research (NIHR) and run through the NHS, so there is no cost to you.
How to find out more
PEARLS Study Team
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.